CSIMarket Company Name, Ticker, Suppliers, else..


Elanco Animal Health Incorporated  (NYSE: ELAN)
Other Ticker:  
 

Elanco Animal Health Incorporated

ELAN's Fundamental analysis



Looking into Elanco Animal Health Incorporated growth rates, revenue grew by 10.39 % in the third quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 10.29 %

Elanco Animal Health Incorporated faced net loss in contrast to the net income a year ago in third quarter of 2025

• More on ELAN's Growth


Elanco Animal Health Incorporated
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 756.79 in trailing twelve-month period.
Company
355.92
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.47.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.


• More on ELAN's Valuation
 
 Total Debt (Millions $) 4,024
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 493,656
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.02
 Tangible Book Value (Per Share $) -3.24

Elanco Animal Health Incorporated
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 756.79 in trailing twelve-month period.
Company
355.92
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.47.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.

Elanco Animal Health Incorporated Price to Book Ratio is at 1.68 lower than Industry Avg. of 39.16. and higher than S&P 500 Avg. of 0.02

• More on ELAN's Valuation

•  Market Capitalization (Millions $) 11,352
•  Shares Outstanding (Millions) 497
•  Employees 9,300
•  Revenues (TTM) (Millions $) 4,591
•  Net Income (TTM) (Millions $) 36
•  Cash Flow (TTM) (Millions $) 15
•  Capital Exp. (TTM) (Millions $) -267
•  Total Debt (Millions $) 4,024
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 493,656
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 5.02
•  Tangible Book Value (Per Share $) -3.24

•  Market Capitalization (Millions $) 11,352
•  Shares Outstanding (Millions) 497
•  Employees 9,300
•  Revenues (TTM) (Millions $) 4,591
•  Net Income (TTM) (Millions $) 36
•  Cash Flow (TTM) (Millions $) 15
•  Capital Exp. (TTM) (Millions $) -267





  Ratio
•   Capital Ratio (MRQ) 3.24
•  Total Debt to Equity (MRQ) 0.6
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.35
•  Inventory Turnover Ratio (TTM) 1.26





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.